DK1471936T3 - HIV-Vaccine og fremgangsmåde til anvendelse - Google Patents
HIV-Vaccine og fremgangsmåde til anvendelseInfo
- Publication number
- DK1471936T3 DK1471936T3 DK03729676.1T DK03729676T DK1471936T3 DK 1471936 T3 DK1471936 T3 DK 1471936T3 DK 03729676 T DK03729676 T DK 03729676T DK 1471936 T3 DK1471936 T3 DK 1471936T3
- Authority
- DK
- Denmark
- Prior art keywords
- hiv vaccine
- pharmaceutical compositions
- compositions
- hiv
- administering
- Prior art date
Links
- 229940033330 HIV vaccine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34869502P | 2002-01-14 | 2002-01-14 | |
| PCT/US2003/001261 WO2003059385A2 (en) | 2002-01-14 | 2003-01-14 | Hiv vaccine and method of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1471936T3 true DK1471936T3 (da) | 2010-04-26 |
Family
ID=23369136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03729676.1T DK1471936T3 (da) | 2002-01-14 | 2003-01-14 | HIV-Vaccine og fremgangsmåde til anvendelse |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20050175631A1 (da) |
| EP (1) | EP1471936B1 (da) |
| AT (1) | ATE458496T1 (da) |
| CA (1) | CA2472579A1 (da) |
| DE (1) | DE60331412D1 (da) |
| DK (1) | DK1471936T3 (da) |
| ES (1) | ES2339762T3 (da) |
| WO (1) | WO2003059385A2 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2449663A1 (en) * | 2001-06-07 | 2002-12-12 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
| AU2002322380B2 (en) | 2001-06-07 | 2006-11-02 | Government Of The United States Of America As Represented By The Uniformed Services University Of The Health Sciences | Mutant forms of cholera holotoxin as an adjuvant |
| AU2003239744B2 (en) * | 2002-05-14 | 2008-07-03 | Novartis Vaccines And Diagnostics S.R.L. | Mucosal combination vaccines for bacterial meningitis |
| GB0302218D0 (en) * | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
| CA2539021A1 (en) * | 2003-09-15 | 2005-03-31 | Chiron Corporation | Combination approaches for generating immune responses |
| EP2357000A1 (en) * | 2005-10-18 | 2011-08-17 | Novartis Vaccines and Diagnostics, Inc. | Mucosal and systemic immunizations with alphavirus replicon particles |
| US20100285062A1 (en) * | 2006-03-31 | 2010-11-11 | Novartis Ag | Combined mucosal and parenteral immunization against hiv |
| WO2009155489A2 (en) | 2008-06-19 | 2009-12-23 | Variation Biotechnologies, Inc. | Compositions and methods for treating influenza |
| EP2451950B9 (en) | 2009-07-06 | 2016-11-23 | Variation Biotechnologies Inc. | Methods for preparing vesicles and formulations produced therefrom |
| US9907746B2 (en) | 2009-07-06 | 2018-03-06 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
| CN102858370A (zh) * | 2010-05-03 | 2013-01-02 | Dcb-美国有限责任公司 | 用作疫苗的多糖与去毒大肠杆菌(e.coli)不耐热肠毒素(lt)的偶联 |
| AU2011276223C1 (en) | 2010-07-06 | 2016-05-12 | Variation Biotechnologies, Inc. | Compositions and methods for treating influenza |
| MX359103B (es) | 2011-01-13 | 2018-09-14 | Variation Biotechnologies Inc | Composiciones y sus usos en el tratamiento de infecciones virales. |
| US20140356399A1 (en) | 2012-01-12 | 2014-12-04 | Variation Biotechnologies, Inc. | Compositions and methods for treating viral infections |
| RU2698906C2 (ru) | 2012-01-27 | 2019-09-02 | Вэриэйшн Биотекнолоджиз, Инк. | Способы и композиции для терапевтических агентов |
| WO2016057617A1 (en) * | 2014-10-08 | 2016-04-14 | Avioq, Inc. | Methods for simultaneous determination of serological profile and estimation of duration post hiv infection |
| CA3004924A1 (en) * | 2015-11-10 | 2017-05-18 | Ohio State Innovation Foundation | Methods and compositions related to accelerated humoral affinity |
| WO2019035972A1 (en) * | 2017-08-16 | 2019-02-21 | Georgia State University Research Foundation, Inc. | SEQUENTIAL IMMUNIZATIONS WITH HIV-1 ENV VIRUS TYPE PARTICLES |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL89567A0 (en) * | 1988-03-28 | 1989-09-10 | Univ Leland Stanford Junior | Mutated hiv envelope protein |
| US5614612A (en) * | 1990-03-09 | 1997-03-25 | Haigwood; Nancy L. | Purified gp120 compositions retaining natural conformation |
| CA2164505A1 (en) * | 1993-06-07 | 1994-12-22 | Phillip W. Berman | Hiv envelope polypeptides |
| US6818222B1 (en) * | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
| JP4918188B2 (ja) * | 1997-12-16 | 2012-04-18 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | サブミクロンの水中油型エマルジョンと合わせた微粒子の使用 |
| AU772617B2 (en) * | 1999-11-19 | 2004-05-06 | Csl Limited | Vaccine compositions |
-
2003
- 2003-01-14 DK DK03729676.1T patent/DK1471936T3/da active
- 2003-01-14 WO PCT/US2003/001261 patent/WO2003059385A2/en active Application Filing
- 2003-01-14 US US10/501,606 patent/US20050175631A1/en not_active Abandoned
- 2003-01-14 ES ES03729676T patent/ES2339762T3/es not_active Expired - Lifetime
- 2003-01-14 DE DE60331412T patent/DE60331412D1/de not_active Expired - Lifetime
- 2003-01-14 EP EP03729676A patent/EP1471936B1/en not_active Expired - Lifetime
- 2003-01-14 CA CA002472579A patent/CA2472579A1/en not_active Abandoned
- 2003-01-14 AT AT03729676T patent/ATE458496T1/de active
-
2008
- 2008-11-28 US US12/324,933 patent/US20090081254A1/en not_active Abandoned
-
2010
- 2010-11-08 US US12/941,176 patent/US20110045017A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2472579A1 (en) | 2003-07-24 |
| EP1471936A2 (en) | 2004-11-03 |
| WO2003059385A3 (en) | 2003-08-21 |
| ES2339762T3 (es) | 2010-05-25 |
| WO2003059385A2 (en) | 2003-07-24 |
| EP1471936B1 (en) | 2010-02-24 |
| ATE458496T1 (de) | 2010-03-15 |
| EP1471936A4 (en) | 2006-10-25 |
| US20050175631A1 (en) | 2005-08-11 |
| DE60331412D1 (de) | 2010-04-08 |
| US20110045017A1 (en) | 2011-02-24 |
| US20090081254A1 (en) | 2009-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1471936T3 (da) | HIV-Vaccine og fremgangsmåde til anvendelse | |
| ATE426412T1 (de) | Adjuvante influenza-vakzine | |
| HK1083192A1 (en) | West nile virus vaccine | |
| CY1118521T1 (el) | Συνθεση εμβολιου και μεθοδος χρησης αυτου | |
| WO2006068663A3 (en) | Vaccine compositions for treating coronavirus infection | |
| HUP0301180A2 (hu) | Imidazokinolinaminok adjuvánsként való használata DNS vakcinálásban | |
| NO20015073L (no) | Vaksiner | |
| DK1928492T3 (da) | Immunologiske anvendelser af immunmodulatoriske forbindelser til vaccine og terapi mod infektionssygdomme | |
| BR0107972A (pt) | Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano | |
| WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
| DK1404363T3 (da) | Adjuvanssammensætning til mucosalt og injektionsfremførte vacciner | |
| CY1112572T1 (el) | Εμβολια γριπης που περιλαμβανουν συνδυασμους σωματιδιακων ανοσοενισχυτικων και ανοσοδιεγερτες | |
| NO20052136L (no) | Vaksine mot Hepatitt C-virus (HCV). | |
| HUP0401606A2 (hu) | West Nile vakcina | |
| GB0109297D0 (en) | Vaccine | |
| CY1111636T1 (el) | Εμβολιο που περιεχει gp120 και nef kai/´h tat για ανοσοποιηση εναντι hiv | |
| PT1409692E (pt) | Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina | |
| ATE401392T1 (de) | Subtypabgestimmte inaktivierte vollvirusvakzine zur behandlung von patienten mit hiv-infektion | |
| ATE460943T1 (de) | Therapeutische mittel als antikrebs impfstoffadjuvantien und deren therapeutische verfahren | |
| MX2007002659A (es) | Composicion vacunal contra el virus de la hepatitis c. | |
| EA200700017A1 (ru) | Способ усиления иммунного ответа на вакцину | |
| HK1080712A1 (en) | Ihnv g protein for immune stimulation | |
| ATE420658T1 (de) | Imidazoquinolinamine als adjuvantien für hiv dna vakzine | |
| BRPI0414073A (pt) | método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo | |
| WO2003032917A3 (en) | Hookworm vaccine |